How to buy Progyny stock - 11 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Progyny stock

Own Progyny stock in just a few minutes.

Progyny, Inc is a health information services business based in the US. Progyny shares (PGNY) are listed on the NASDAQ and all prices are listed in US Dollars. Progyny employs 210 staff and has a trailing 12-month revenue of around USD$344.9 million.

How to buy shares in Progyny

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Progyny. Find the stock by name or ticker symbol: PGNY. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Progyny reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Progyny, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Progyny. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Progyny share price

Use our graph to track the performance of PGNY stocks over time.

Progyny shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$18.77 - USD$53.48
50-day moving average USD$46.1165
200-day moving average USD$38.9498
Wall St. target priceUSD$53.75
PE ratio 792.6763
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.1043

Buy Progyny shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Progyny stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Progyny under- or over-valued?

Valuing Progyny stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Progyny's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Progyny's P/E ratio

Progyny's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 793x. In other words, Progyny shares trade at around 793x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Progyny's EBITDA

Progyny's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$19.6 million.

The EBITDA is a measure of a Progyny's overall financial performance and is widely used to measure a its profitability.

Progyny financials

Revenue TTM USD$344.9 million
Operating margin TTM 5.12%
Gross profit TTM USD$70.1 million
Return on assets TTM 5.46%
Return on equity TTM 33.04%
Profit margin 13.47%
Book value N/A
Market capitalisation USD$3.9 billion

TTM: trailing 12 months

Shorting Progyny shares

There are currently 2.2 million Progyny shares held short by investors – that's known as Progyny's "short interest". This figure is 6.3% up from 2.0 million last month.

There are a few different ways that this level of interest in shorting Progyny shares can be evaluated.

Progyny's "short interest ratio" (SIR)

Progyny's "short interest ratio" (SIR) is the quantity of Progyny shares currently shorted divided by the average quantity of Progyny shares traded daily (recently around 846669.921875). Progyny's SIR currently stands at 2.56. In other words for every 100,000 Progyny shares traded daily on the market, roughly 2560 shares are currently held short.

However Progyny's short interest can also be evaluated against the total number of Progyny shares, or, against the total number of tradable Progyny shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Progyny's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Progyny shares in existence, roughly 20 shares are currently held short) or 0.1584% of the tradable shares (for every 100,000 tradable Progyny shares, roughly 158 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Progyny.

Find out more about how you can short Progyny stock.

Progyny share dividends

We're not expecting Progyny to pay a dividend over the next 12 months.

Progyny overview

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site